$3.180
-0.010 (-0.31%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ESPR Prediction & Forecast by Similar Chart Analysis
Alphio's ESPR stock price prediction model matches the current Esperion Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.22 (+1.24%). The 1-week path is $3.31 (+4.21%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Esperion Therapeutics Inc Stock?
ESPR is not a good buy right now for a Beginner long-term investor with $50,000-$100,000 to deploy. The stock is effectively priced at the acquisition level of $3.16, leaving very limited upside from the current $3.17 close. Since the investor is impatient and does not want to wait for a better entry, the best direct conclusion is to avoid buying new shares now and wait for a clearer catalyst or a better risk/reward setup. If already holding, this is more of a hold than an aggressive buy.
ESPR stock price ended at $3.18 on Friday, after losing -0.31%
Esperion Therapeutics Inc (ESPR) last closed at $3.18, losing -0.31%. These facts feed the 1-day and 1-week ESPR price prediction above.
Analyst Consensus
Esperion Therapeutics Inc (ESPR): 9 buy, 2 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Esperion Therapeutics Inc (ESPR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches ESPR, ranked by similarity.
Seasonality analysis for ESPR
Historically the probability of a positive August return for ESPR is 4.65%. December offers the highest probability of a positive month at 67.44%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ESPR
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $0.79 | $1.01 | $1.03 | -68.16% |
| Sep 2026 | $0.96 | $1.02 | $1.18 | -67.83% |
| Oct 2026 | $0.96 | $1.27 | $1.29 | -60.04% |
| Nov 2026 | $1.01 | $1.03 | $1.19 | -67.61% |
| Dec 2026 | $0.86 | $1.21 | $1.26 | -62.09% |
In 2026, Esperion Therapeutics Inc (ESPR) is projected to range from $0.79 to $1.29.
Esperion Therapeutics Inc 2026 monthly forecast
In Aug 2026, Esperion Therapeutics Inc is projected to average $1.01, with a low of $0.79 and high of $1.03.
In Sep 2026, Esperion Therapeutics Inc is projected to average $1.02, with a low of $0.96 and high of $1.18.
In Oct 2026, Esperion Therapeutics Inc is projected to average $1.27, with a low of $0.96 and high of $1.29.
In Nov 2026, Esperion Therapeutics Inc is projected to average $1.03, with a low of $1.01 and high of $1.19.
In Dec 2026, Esperion Therapeutics Inc is projected to average $1.21, with a low of $0.86 and high of $1.26.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.